Uncategorized US Equities: VSCO Beats Estimates Amid Micro-Cap RestructuringsGlobal Report·Aug 27 at 10:14 AMCOPR+3.04%ERNA-0.22%
Liminatus Pharma sets 1-for-50 reverse stock split effective Aug. 20PUBT·Aug 18 at 08:01 PMLIMN-3.65%
Unpacking Market Pockets: Pinterest's AI Ads Play and Heavy Moves in MiningGlobal Report·Aug 18 at 10:12 AMPINS-1.74%WMB-1.48%
Liminatus Pharma Q2 FY26 net loss widens to $1.41 million; operating loss widens 23% to $1.38 millionPUBT·Aug 14 at 08:52 PMLIMN-3.65%
Liminatus Pharma tumbles 8% in after-hours trading as Nasdaq compliance extension follows 50% rallyUS Stock Market Update·Aug 13 at 11:01 PMLIMN-3.65%
Liminatus Pharma (LIMN) Stock Jumps Over 50% on a Listing UpdateTip Ranks·Aug 13 at 06:11 PMLIMN-3.65%
Liminatus Pharma jumps 52% after Nasdaq tier adjustment and compliance extensionUS Stock Market Update·Aug 13 at 05:22 PMLIMN-3.65%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Aug 13 at 05:05 PMBYSI+1.83%OMER+1.33%
Liminatus Pharma surges 51% during regular trading as premarket spike draws attentionUS Stock Market Update·Aug 13 at 01:50 PMLIMN-3.65%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Aug 13 at 12:05 PMABEO-0.34%NRC+6.20%
Fragmented Flows: How Unclassified U.S. Equities Reflect a Complex 2026 Macro LandscapeGlobal Report·Aug 11 at 10:13 AMALGM+0.25%AUR+8.03%
New Infrastructure Contracts and Biotech Maneuvers: The Latest Sector ShakeupGlobal Report·Aug 9 at 09:12 AMGNPX-2.42%LIMN-3.65%
The Biotech Divide of 2026: Commercial Titans vs. AI HopefulsGlobal Report·Aug 8 at 09:21 AMRAIN+0.63%GENB+0.37%
Specialized Firms From AI to Biotech Advance 2026 Commercial MilestonesGlobal Report·Aug 7 at 09:18 AMDRTS+2.02%LSE0.00%
